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Abstract Cystic	   fibrosis	   (CF)	   patients	   are	   immunocompromised	   and	   often	   suffer	   from	  polymicrobial	   infections	   involving	   Pseudomonas	   aeruginosa,	   an	   opportunistic	   bacterial	  pathogen.	   P.	   aeruginosa	   pathogenicity	   is	   influenced	   by	   the	   secretion	   of	   bacterial	  compounds	   such	   as	   quinolones.	   P.	   aeruginosa	   secretes	   at	   least	   50	   different	   quinolone-­‐based	  molecules.	  Although	  two	  of	  these,	  PQS	  and	  HHQ,	  are	  signals	  for	  a	  bacterial	  quorum	  sensing	   system,	   there	   are	   no	   known	   roles	   for	   the	   majority	   of	   the	   quinolones.	   A	   third	  quinolone	   molecule,	   HQNO,	   is	   secreted	   at	   high	   levels	   in	   culture.	   Preliminary	   data	   using	  macrophages	   suggest	   that	   HQNO	   inhibits	   respiratory	   burst,	   the	   process	   by	   which	  eukaryotic	   cells	   kill	   phagocytosed	   bacteria	   with	   reactive	   oxygen.	   Respiratory	   burst	   is	  known	   to	   be	   regulated	   by	   the	   mammalian	   target	   of	   rapamycin	   pathway	   (mTOR).	   We	  hypothesize	  that	  HQNO	  inhibits	  mTOR	  and	  thus	  the	  ability	  of	  macrophages	  to	  kill	  bacteria	  such	   as	   P.	   aeruginosa	   and	   the	   secondary	   pathogen	   Burkholderia	   multivorans.	   We	   used	  western	   blotting	   to	   demonstrate	   that	   in	   HQNO-­‐treated	   mouse	   embryonic	   fibroblasts	  (MEFs),	  phosphorylation	  of	  the	  mTOR	  inhibitor	  AMPK	  was	  increased,	  and	  phosphorylation	  of	  the	  downstream	  mTOR	  effector,	  S6	  ribosomal	  protein	  was	  reduced,	   in	  a	  time	  and	  dose	  dependent	  manner.	  Next,	  we	  tested	  whether	  bacterial	  killing	  by	  RAW	  264.7	  macrophages	  depended	  on	  HQNO.	  We	  found	  that	  HQNO	  treatment	  decreased	  killing	  of	  P.	  aeruginosa	  and	  





















Introduction 	  	  	  	  	  	  	  	  	   Cystic	  fibrosis	  (CF)	  is	  an	  autosomal	  recessive	  genetic	  disorder	  caused	  by	  a	  mutation	  of	   the	   CFTR	   gene.	   Defective	   CFTR	   results	   in	   the	   build	   up	   of	   thick	  mucus	   in	   the	   airways,	  pancreas,	   and	   other	   mucus	   secreting	   organs.	   CF	   affects	   approximately	   70,000	   people	  worldwide.	   Currently,	   the	   median	   life	   expectancy	   for	   individuals	   with	   CF	   in	   the	   United	  States	   is	   40	   years	   old;	   approximately	   half	   the	   normal	   life	   expectancy.	   CF	   leaves	   the	   host	  susceptible	   to	   frequent	   and	   chronic	   lung	   infection	   by	   opportunistic	   pathogens	   [1].	  
Pseudomonas	  aeruginosa	  is	  the	  most	  common	  pathogen	  that	  infects	  CF	  patients. 	  	  	  	  	  	  	  	  	   Pseudomonas	   aeruginosa	   is	   a	   gram-­‐negative	  mucosal	   bacterium	   that	   often	   infects	  immunosuppressed	   and	   immunocompromised	   individuals	   [2].	   The	   production	   and	  secretion	   of	   small	  molecules	   play	   an	   integral	   role	   in	   the	   pathogenicity	   of	  many	   bacteria.	  Previous	  studies	  have	  shown	  that	  P.	  aeruginosa	  releases	  at	  least	  50	  different	  quinolone-­‐like	  molecules.	  Although	  two	  of	  these,	  PQS	  and	  HHQ,	  are	  signals	  for	  a	  quorum	  sensing	  system	  (cell-­‐to-­‐cell	   signaling),	   there	   are	   no	   known	   roles	   for	   the	  majority	   of	   these	   quinolones	   in	  
Pseudomonas.	  A	  third	  quinolone	  molecule,	  HQNO,	  is	  secreted	  at	  high	  levels	  in	  culture.	  PQS,	  HHQ,	  and	  HQNO	  have	  all	  been	  detected	  in	  the	  sputum	  of	  CF	  patients	  when	  infected	  with	  P.	  
aeruginosa	  [3][4]. While	  P.	  aeruginosa	  is	  the	  primary	  pathogen	  in	  the	  CF	  lung,	  CF	  airway	  infections	  are	  polymicrobial	   and	   often	   involve	   the	   acquisition	   of	   other	   secondary	   pathogens	   including	  
Burkholderia	   species.	   It	   is	   believed	   that	   the	  polymicrobial	   nature	   of	   CF	   airway	   infections	  contributes	   to	   a	   rapid	   decline	   in	   lung	   function	   [5].	   Burkholderia	   species,	   unlike	   P.	  
aeruginosa,	  are	  highly	  susceptible	  to	  killing	  by	  reactive	  oxygen	  released	  during	  respiratory	  burst,	  which	  is	  a	  process	  that	  delivers	  reactive	  oxygen	  species	  into	  a	  pathogen	  containing	  vacuole	  [6].	  Previous	  research	  in	  the	  Wolfgang	  lab	  suggests	  that	  HQNO	  inhibits	  respiratory	  burst	   in	   macrophages.	   We	   hypothesize	   that	   P.	   aeruginosa	   produced	   HQNO	   inhibit	   the	  ability	   of	   macrophages	   to	   kill	   Burkholderia	   multivorans,	   thus	   facilitating	   polymicrobial	  infection	  in	  CF. The	  primary	  host	  enzyme	  that	  generates	  reactive	  oxygen	  is	  NADPH	  oxidase	  [7].	  The	  synthesis	   of	   NADPH	   oxidase	   and	   thus	   respiratory	   burst	   is	   regulated	   through	   the	  mammalian	  Target	  of	  Rapamycin	  pathway	  (mTOR)	  [8].	  The	  mTOR	  pathway	  plays	  a	  central	  role	  in	  controlling	  a	  wide	  variety	  of	  important	  activities	  in	  the	  innate	  and	  adaptive	  immune	  
system	  [9][4].	  mTOR	  is	  controlled	  by	  a	  number	  of	  protein	  kinases,	  including	  AMP-­‐activated	  protein	  kinase	  (AMPK)	  [10].	  	  AMPK	  is	  a	  kinase	  naturally	  active	  when	  there	  is	  a	  high	  AMP	  to	  ATP	   ratio	   in	   the	   cell,	   which	   usually	   occurs	   when	   cells	   are	   metabolically	   active	   [11].	   To	  summarize,	   an	   active	   mTOR	   pathway	   leads	   to	   the	   phosphorylation	   of	   the	   S6	   ribosomal	  protein	   and	   AMPK	   is	   a	   mTOR	   inhibitor	   when	   phosphorylated.	   We	   hypothesize	   HQNO	  causes	   dysregulation	   of	   host	   mTOR	   signaling	   and	   thus	   decreases	   the	   killing	   ability	   of	  macrophages.	   	  	  	  	  	  	  	  	  	   The	  role	   that	  HQNO	  plays	  on	   the	  host	   innate	   immune	  response	   is	  not	  known.	  The	  goal	   of	   our	   study	   was	   to	   understand	   the	   impact	   that	   HQNO	   has	   on	   the	   ability	   of	  macrophages	  to	  kill	  bacteria.	  Western	  blotting	  was	  used	  to	  show	  that	  HQNO	  dysregulates	  the	  mTOR	  pathway.	  Macrophages	  were	  observed	  to	  be	  less	  efficient	  at	  killing	  P.	  aeruginosa	  and	  B.	  multivorans	  when	  treated	  with	  HQNO.	  A	  better	  understanding	  of	  the	  effects	  of	  HQNO	  may	  lead	  to	  treatment	  options	  that	  can	  combat	  the	  negative	  consequences	  this	  molecule.	   
 
Materials	  and	  Methods Cell	  Culture	  and	  Bacterial	  Strains 	  	  	  	  	  	  	  	  	   Mouse	   Raw	   264.7	  macrophages	   (RAW)	   and	   immortalized	   10.1	  Mouse	   Embryonic	  Fibroblasts	   (MEF)	   cell	   lines	   were	   grown	   in	   Dulbecco’s	   Modified	   Eagle	   Medium	   (DMEM)	  with	   10%	   Fetal	   Bovine	   Serum	   (Sigma-­‐Aldrich)	   and	   1%	   Penicillin-­‐Streptomycin	   (Life-­‐Technologies).	   Bacterial	  Killing	  Assay 	  	  	  	  	  	  	  	  	   RAW	  macrophages	  were	  plated	  onto	  24	  well	  plates	  at	  a	  density	  of	  250,000	  cells	  per	  well	  and	  incubated	  for	  24	  hours.	  Cells	  were	  treated	  with	  1	  μM	  Torin1	  (Cayman	  Chemical),	  a	  known	  mTOR	  inhibitor,	  or	  1	  or	  10	  μM	  HQNO	  (Cayman	  Chemical).	  Approximately	  16	  hours	  after	  treating,	  the	  cells	  were	  primed	  with	  100	  ng/ml	  E.	  coli	  lipopolysaccharide	  (Sigma)	  and	  20	  ng/ml	  mouse	  interferon	  gamma	  (Peprotech)	  for	  one	  hour.	  Next,	  the	  cells	  were	  infected	  with	   Burkholderia	   multivorans	   in	   media	   lacking	   antibiotics	   to	   achieve	   an	   MOI	   of	   1.	   The	  plates	   were	   spun	   down	   in	   the	   centrifuge	   at	   500	   relative	   centrifugal	   force	   (rcf)	   for	   five	  minutes	   to	   ensure	   contact	   between	   the	   bacteria	   and	   the	   RAW	  macrophages.	   The	   plates	  were	  incubated	  for	  one	  hour	  to	  allow	  for	  phagocytosis.	  The	  media	  was	  then	  aspirated	  and	  media	   containing	   100	   μg	   of	   kanamycin	   per	  mL	   of	  media	  was	   added.	   At	   each	   designated	  
time,	  one	  set	  of	  wells	  for	  each	  condition	  were	  lysed	  and	  plated.	  The	  cells	  were	  lysed	  using	  0.01%	  Triton	  and	  plated	  on	  tryptic	  soy	  agar	  plates	  at	  10	  fold	  dilutions.	  Plates	  were	  left	  at	  37°C	  and	  then	  colonies	  were	  counted	  after	  they	  became	  visible.	  Data	  at	  each	  time	  point	  are	  expressed	  as	  percent	  of	  bacteria	  killed	   compared	   to	   time	  zero	   for	   a	   given	   condition.	  The	  same	  protocol	  was	  carried	  out	  using	  P.	  aeruginosa	  using	  gentamicin	  instead	  of	  kanamycin.	   Western	  Blot MEF	  or	  RAW	  cells	  are	  plated	  onto	  24	  well	  plates	  at	  a	  density	  of	  250,000	  cells	  per	  well	  and	  incubated.	  24	  hours	  later,	  the	  cells	  were	  treated	  with	  Torin1	  or	  HQNO.	  Depending	  on	  the	  experiment,	  cells	  may	  or	  may	  not	  have	  been	  primed	  using	  the	  same	  concentration	  of	  interferon	   gamma	   and	   LPS	   previously	   described.	   Next,	   50	   μL of	   Radio	   Immuno	  Precipitation	  Assay	  buffer	  (Boston	  BioProducts)	  with	  (1%)	  Halt	  Protease	  and	  Phosphatase	  Inhibitor	   Cocktail	   100x	   (Thermo	   Fisher	   Scientific)	  was	   added	   to	   each	  well.	   The	   samples	  were	   then	   transferred	   to	   1.5	   ml	   Eppendorf	   tubes.	   6x	   Loading	   buffer	   with	   5%	   beta-­‐mercaptoethanol	  was	  added	  to	  the	  samples.	  The	  mixture	  was	  boiled	  for	  5	  minutes	  and	  then	  proteins	  were	  separated	  on	  a	  12%	  SDS-­‐polyacrylamide	  gel.	  The	  SDS	  gel	  was	  run	  for	  about	  an	  hour,	   followed	  by	   transfer	  of	  proteins	   to	  a	  nitrocellulose	  membrane.	  The	   transfer	  was	  run	   for	  another	  hour.	  Next,	  LI-­‐COR	  Odyssey	  Blocking	  Buffer	  was	  used	  to	  block	  overnight.	  The	   membrane	   was	   washed	   3	   times	   for	   five	   minutes	   using	   PBS	   with	   (1%)	   Tween-­‐20.	  Rabbit	   Anti-­‐phospho-­‐S6	   ribosomal	   protein	   and	   rabbit	   anti-­‐phospho-­‐AMPK	   primary	  antibodies	  (Cell	  Signaling	  Technologies)	  were	  diluted	   in	  PBS-­‐Tween	  1:2,000	  added	  to	  the	  membrane	   incubated	   overnight.	   The	  membrane	  was	  washed	   3	   times	   for	   5	  minutes	  with	  PBS-­‐Tween	   and	   IRDye	   Goat	   Anti-­‐Rabbit	   800CW	   (LICOR)	   secondary	   antibody	   diluted	  1:10,000	   in	   PBS	   tween	  was	   added	   for	   an	   hour.	   Lastly,	   the	  membrane	  was	  washed	   three	  times	  and	  then	  imaged	  with	  a	  LI-­‐COR	  Odyssey	  Imaging	  System.	  Blots	  were	  similarly	  probed	  for	   total	   AMPK	   and	   total	   S6	   ribosomal	   protein	   except	   the	   goat-­‐anti-­‐mouse-­‐680LT	  secondary	  antibody	  was	  used	  to	  visualize	  S6	  ribosomal	  protein.	   
	  
Results mTOR	  Inhibition 	  	  	  	  	  	  	  	  	   The	  innate	  immune	  response,	  specifically	  the	  production	  of	  reactive	  oxygen	  species,	  is	   regulated	   by	   the	  mTOR	  pathway.	   As	   a	   first	   step	   to	   determine	   if	   HQNO	   alters	   the	   host	  
immune	  response,	  we	  assessed	  whether	  mTOR	  is	  inhibited	  in	  cells	  treated	  with	  HQNO.	  To	  do	  this	  western	  blotting	  was	  used	  to	  view	  the	  presence	  of	  phosphorylated	  AMPK	  and	  S6.	  AMPK	   is	   an	   upstream	   mTOR	   inhibitor	   when	   phosphorylated	   and	   S6	   is	   a	   protein	  downstream	  of	  the	  mTOR	  pathway	  that	  becomes	  phosphorylated	  when	  mTOR	  is	  active.	  We	  hypothesized	   that	   HQNO	   inactivates	   the	   mTOR	   pathway	   due	   to	   the	   phosphorylation	   of	  AMPK.	   	  	  	  	  	  	  	  	  	   Figure	   1	   illustrates	   an	   increase	   in	   AMPK	   phosphorylation	   as	   the	   dosage	   of	  HQNO	  increases.	   This	   figure	   also	   shows	   that	   phosphorylation	   of	   S6	   protein	   is	   dose-­‐dependent.	  AMPK	  seems	   to	  be	  phosphorylated	  at	   as	   little	   as	  1	  μM	  HQNO,	  but	  phosphorylation	  of	   S6	  starts	  to	  become	  inhibited	  at	  2.5	  μM	  HQNO.	  Figure	  2	  indicates	  that	  AMPK	  is	  phosphorylated	  as	   early	   as	   one	   hour	   after	  MEF	   cells	   are	   treated	  with	  HQNO.	   The	   blots	   also	   display	   that	  although	  AMPK	  is	  phosphorylated	  quickly,	  S6	  phosphorylation	  starts	  to	  become	  inhibited	  around	  6	  hours	  post	  treatment.	  	  	  
 Bacterial	  Killing	  Assay Respiratory	  burst	   is	   a	  host	   immune	   response	   that	  uses	   reactive	  oxygen	   species	   to	  kill	  bacteria.	  Since	  HQNO	  treatment	  led	  to	  considerable	  mTOR	  inhibition,	  we	  next	  wanted	  to	  determine	  if	  HQNO	  could	  alter	  the	  killing	  ability	  of	  macrophages.	  To	  view	  this,	  we	  set	  up	  bacterial	  killing	  assays	  using	  both	  B.	  multivorans	  and	  P.	  aeruginosa	  and	  RAW	  macrophage	  cell	  lines.	   Initially,	   we	   chose	   B.	   multivorans	   as	   a	   candidate	   bacteria	   for	   the	   killing	   assay	  because	   it	   is	   known	   to	   be	   susceptible	   to	   respiratory	   burst.	   Macrophages	   that	   were	   not	  treated	  with	  HQNO	  killed	   approximately	   60%	  of	   intracellular	  B.	  multivorans	   in	   one	  hour	  (Figure	   3).	   This	   killing	   efficiency	   dropped	   to	   approximately	   20%	   for	   1	   uM	  HQNO	   and	   to	  about	  0%	  killing	  for	  10	  μM	  HQNO	  conditions.	  Torin,	  a	  known	  inhibitor	  of	  mTOR,	  was	  used	  as	  a	  control.	  Torin	  treatment	  resulted	  in	  approximately	  5%	  of	  bacteria	  killed.	  These	  results	  demonstrate	  that	  bacterial	  killing	  is	  impaired	  in	  cells	  treated	  with	  HQNO	  concentrations	  of	  1	  and	  10	  μM	  and	  reduced	  killing	  is	  likely	  to	  be	  mediated	  by	  mTOR	  inhibition	  (Figure	  3).	   We	  also	  wanted	  to	  view	  the	  effect	  of	  HQNO	  on	  the	  host	  response	  to	  P.	  aeruginosa.	  Untreated	   macrophages	   killed	   approximately	   60%	   of	   intracellular	   P.	   aeruginosa	   in	   30	  minutes.	  When	  treated	  with	  1	  and	  10	  μM	  HQNO,	  macrophages	  killed	  approximately	  35%	  
and	  10%	  of	  intracellular	  P.	  aeruginosa,	  respectively.	  Lastly,	  treating	  the	  cells	  with	  Torin	  did	  not	  result	  in	  a	  major	  decrease	  in	  bacterial	  killing.	   
 
Discussion 	  	  	  	  	  	  	  	  	   We	  studied	  the	  effect	  of	  P.	  aeruginosa	  released	  HQNO	  on	  the	  mTOR	  pathway	  and	  the	  killing	  ability	  of	  host	  immune	  cells.	  Initially,	  western	  blot	  analysis	  was	  used	  to	  determine	  if	  HQNO	  dysregulates	  the	  mTOR	  pathway.	  After	  a	  16-­‐hour	  incubation,	  the	  phosphorylation	  of	  the	  S6	  ribosomal	  protein,	  and	  thus	  mTOR,	   is	   inhibited	  at	  HQNO	  concentrations	  above	  2.5	  μM	  (Figure	  1).	  We	  determined	  that	  as	  the	  concentration	  of	  HQNO	  increased,	  the	  strength	  of	  inhibition	  increased.	  Furthermore,	  HQNO	  was	  seen	  to	  lead	  to	  phosphorylation	  of	  AMPK	  at	  every	  concentration	  (Figure	  1).	  Although	  the	  bands	  for	  phosphorylated	  AMPK	  were	  poorly	  resolved,	  the	  blots	  were	  still	  analyzed.	  These	  results	  will	  be	  repeated	  with	  new	  antibodies.	   After	   discovering	   that	   HQNO	   inhibits	   mTOR	   in	   MEF	   cells,	   we	   next	   wanted	   to	  determine	  the	  kinetics	  at	  which	  this	  process	  occurred.	  HQNO	  at	  a	  high	  concentration	  (10	  μM)	   results	   in	   the	  phosphorylation	  of	  AMPK	  beginning	  at	   one	  hour	   (Figure	  2).	  However,	  disruption	  of	  S6	  phosphorylation	  does	  not	  start	  until	  6	  hours	  post-­‐treatment	  with	  10	  μM	  HQNO	   (Figure	   2).	   This	   could	   be	   due	   to	   a	   threshold	   of	   phosphorylated	   AMPK	   being	  necessary	   for	   the	   full	   inhibition	   of	   the	  mTOR	   pathway.	  Western	   blots	  will	   be	   quantified	  using	   ImageJ	   in	   future	   experiments.	   Additional	   experiments	   showed	   that	   HQNO	   also	  inhibits	  mTOR	  in	  bone	  marrow	  derived	  macrophages	  (data	  not	  shown).	  In	  these	  additional	  experiments,	   tubulin	   levels	   were	   probed	   for	   to	   ensure	   similar	   total	   protein	   levels	   in	  samples	  (data	  not	  shown). Since	   it	   is	   known	   that	   an	   active	   mTOR	   pathway	   leads	   to	   respiratory	   burst,	   we	  investigated	  if	  treating	  cells	  with	  HQNO	  was	  sufficient	  to	  hinder	  the	  bacterial	  killing	  ability	  of	   RAW	   macrophages.	   RAW	   cells	   ability	   to	   kill	   B.	   multivorans	   and	   P.	   aeruginosa	   is	  substantially	  reduced	  when	  treated	  with	  HQNO.	  Torin	  treatment	  led	  to	  decreased	  killing	  of	  
B.	   multivorans,	   but	   its	   effect	   on	   P.	   aeruginosa	  was	   not	   as	   strong.	   This	   could	   be	   due	   to	  immune	  responses,	  other	  than	  respiratory	  burst,	  targeting	  P.	  aeruginosa.	  For	  example,	  it	  is	  known	   that	   the	   NLRP3	   and	   NLRC4	   inflammasome	   target	   P.	   aeruginosa	   in	   addition	   to	  respiratory	   burst.	   	   As	   such,	   it	   is	   possible	   that	   HQNO	   treatment	   may	   inhibit	   additional	  pathways	   not	   directly	   regulated	   by	   mTOR.	   This	   would	   explain	   why	   Torin	   might	   inhibit	  




Figure 1: Treatment of MEF cells with HQNO results in decreased 
phosphorylation of S6 protein and increased phosphorylation of AMPK. 
MEFs were treated for 16 hours with the indicated concentration of 
HQNO or not treated. Western blots of cell lysates were probed with 





Figure 2: Kinetics of HQNO-dependent phosphorylation of S6 
ribosomal protein and AMPK. All MEFs were treated with 10 μM 
HQNO. MEFs were treated for different durations of time or were left 
untreated. Western blot for cell lysate was probed with anti-phospho-




Figure 3: The ability of macrophages to kill B. multivorans was 
dampened by HQNO.  RAW macrophages were treated for 16 hours 
with indicated concentration of HQNO or Torin. After phagocytosis 
and killing of extracellular bacteria with kanamycin, killing of 
phagocytosed bacteria was assessed at 30 minutes. This figure 
depicts a single killing assay with three sets of cells per condition, but 
is representative of two more replicates.  Error bars show standard 
deviation. HQNO 1µM, 10µM, and Torin 1µM treated conditions had 






Figure 4: The ability of macrophages to kill P. aeruginosa was 
dampened by HQNO.  RAW macrophages were treated for 16 hours 
with indicated concentration of HQNO or Torin. After phagocytosis 
and killing of extracellular bacteria with kanamycin, killing of 
phagocytosed bacteria was assessed at 1 hour. This figure depicts a 
single killing assay with three sets of cells per condition, but is 
representative of one more replicate. Error bars show standard 
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